Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
Dec 9, 2025 - ADVM was delisted (reason: acquired by LLY)
4.360
+0.100 (2.35%)
Inactive · Last trade price on Dec 8, 2025

Adverum Biotechnologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
-13.6-7.5-
Revenue Growth
--72.22%----
Gross Profit
-13.6-7.5-
Operating Income
-188.72-139.16-128.94-157.14-146.12-117.95
Net Income
-184.79-130.93-122.12-154.54-145.54-117.51
Earnings Per Share
-8.58-6.62-12.11-15.60-14.80-13.80
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
26.06125.6996.53185.59305.19429.73
Total Debt
88.9491.7174.04106.8102.9930.71
Net Cash (Debt)
-62.8833.9922.4978.79202.19399.02
Net Cash Growth
-51.15%-71.46%-61.03%-49.33%198.25%
Net Cash Per Share
-2.911.722.237.9420.6246.86

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-130.91-92.46-90.9-108.09-107.83-79.29
Capital Expenditures
-0.62-0.39-0.81-11.82-15.12-11.84
Free Cash Flow
-131.53-92.85-91.71-119.91-122.95-91.14
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-100.00%100.00%-100.00%-
Operating Margin
--13915.90%-3581.72%--1948.29%-
Pretax Margin
--13092.70%-3422.06%--1940.53%-
Profit Margin
--13092.70%-3392.11%--1940.53%-
FCF Margin
--9285.00%-2547.50%--1639.39%-

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
-97.3621.22-23.09-